Cocrystal Pharma Stock Price, News & Analysis (OTCMKTS:COCP)

$0.19 -0.01 (-4.89 %)
(As of 01/17/2018 04:00 PM ET)
Previous Close$0.20
Today's Range$0.19 - $0.20
52-Week Range$0.16 - $0.41
Volume122,206 shs
Average Volume180,368 shs
Market Capitalization$145.65 million
P/E Ratio-1.95
Dividend YieldN/A
Beta2.47

About Cocrystal Pharma (OTCMKTS:COCP)

Cocrystal Pharma, Inc., formerly Biozone Pharmaceuticals, Inc., is engaged in developing medicines for use in the treatment of human viral diseases. The Company develops technologies and approaches to create antiviral drug candidates. The Company is developing antiviral therapeutics that inhibit the replication function of a virus, including the ribonucleic acid (RNA)-dependent RNA polymerase enzyme, the helicase enzyme and the NS5A protein of hepatitis C virus (HCV), and the polymerase enzymes of influenza virus and norovirus. The polymerase inhibitors include both nucleosides (Nucs) and non-nucleosides. Its platform consists of computation, medicinal chemistry, click chemistry and X-ray crystallography. The Company determines the structures of cocrystals containing the inhibitors bound to the enzyme or protein to guide its design. The Company uses computational methods to screen and design product candidates using its cocrystal structural information.

Receive COCP News and Ratings via Email

Sign-up to receive the latest news and ratings for COCP and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Drug Related Products
Sub-IndustryN/A
SectorHealthcare
SymbolOTCMKTS:COCP
CUSIPN/A
Phone+1-425-3987178

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E Ratio-1.945
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPS($0.10)
Net IncomeN/A
Net MarginsN/A
Return on Equity-8.97%
Return on Assets-7.35%

Miscellaneous

EmployeesN/A
Outstanding Shares726,530,000

Cocrystal Pharma (OTCMKTS:COCP) Frequently Asked Questions

What is Cocrystal Pharma's stock symbol?

Cocrystal Pharma trades on the OTCMKTS under the ticker symbol "COCP."

Who are some of Cocrystal Pharma's key competitors?

Who are Cocrystal Pharma's key executives?

Cocrystal Pharma's management team includes the folowing people:

  • Raymond F. Schinazi Ph.D., Chairman of the Board (Age 65)
  • Sam Lee, President (Age 56)
  • Gary L. Wilcox Ph.D., Interim Chief Executive Officer, Vice Chairman of the Board (Age 69)
  • James J. Martin, Chief Financial Officer (Age 50)
  • David S. Block M.D., , Director (Age 56)
  • Phillip Frost, Director (Age 79)
  • Jane Hsiao Ph.D., M.B.A.,, Director (Age 68)
  • Steven Rubin, Director (Age 55)

How do I buy Cocrystal Pharma stock?

Shares of Cocrystal Pharma can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Cocrystal Pharma's stock price today?

One share of Cocrystal Pharma stock can currently be purchased for approximately $0.19.

How big of a company is Cocrystal Pharma?

Cocrystal Pharma has a market capitalization of $145.65 million.

How can I contact Cocrystal Pharma?

Cocrystal Pharma's mailing address is 1860 Montreal Rd, TUCKER, GA 30084-5709, United States. The company can be reached via phone at +1-425-3987178.


MarketBeat Community Rating for Cocrystal Pharma (COCP)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  17 (Vote Outperform)
Underperform Votes:  18 (Vote Underperform)
Total Votes:  35
MarketBeat's community ratings are surveys of what our community members think about Cocrystal Pharma and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Cocrystal Pharma (OTCMKTS:COCP) Analyst Ratings History


No equities research coverage for this company has been tracked by MarketBeat

Earnings

Earnings History for Cocrystal Pharma (OTCMKTS:COCP)


No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Cocrystal Pharma (OTCMKTS:COCP) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Cocrystal Pharma (OTCMKTS:COCP)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Cocrystal Pharma (OTCMKTS COCP) Insider Trading and Institutional Ownership History

Insider Trades by Quarter for Cocrystal Pharma (OTCMKTS:COCP)

Cocrystal Pharma (OTCMKTS COCP) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/23/2016Sam LeePresidentSell2,200,000$0.44$968,000.0013,087,847View SEC Filing  
9/1/2016Gary WilcoxCEOBuy10,000$0.41$4,100.00View SEC Filing  
9/1/2016Raymond F SchinaziDirectorBuy4,878,050$0.41$2,000,000.50275,520,853View SEC Filing  
3/15/2016Jane Ph D HsiaoDirectorBuy1,235,294$0.51$629,999.943,435,294View SEC Filing  
3/15/2016Jeffrey A MecklerCEOBuy294,118$0.51$150,000.18657,161View SEC Filing  
12/23/2015Jeffrey A MecklerCEOBuy100,000$0.58$58,000.00363,043View SEC Filing  
4/21/2015Raymond F SchinaziDirectorBuy3,464,855$0.92$3,187,666.60View SEC Filing  
3/25/2015Gary WilcoxCEOBuy54,348$0.92$50,000.16View SEC Filing  
3/25/2015Jeffrey A MecklerDirectorBuy163,043$0.92$149,999.56View SEC Filing  
12/15/2014Phillip Md Et Al FrostDirectorBuy25,000$0.43$10,750.00View SEC Filing  
8/12/2014Phillip Md Et Al FrostDirectorBuy111,200$0.29$32,248.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Cocrystal Pharma (OTCMKTS COCP) News Headlines

Source:
DateHeadline
Cocrystal Pharma Announces Filing 2017 Third Quarter Financial Statements and Provides Company UpdateCocrystal Pharma Announces Filing 2017 Third Quarter Financial Statements and Provides Company Update
finance.yahoo.com - November 8 at 9:40 PM
Cocrystal Pharma to Present at the 2017 Cantor Fitzgerald Global Healthcare Conference in New YorkCocrystal Pharma to Present at the 2017 Cantor Fitzgerald Global Healthcare Conference in New York
finance.yahoo.com - September 22 at 9:46 AM
Cocrystal Pharma, HitGen and InterX Enter into Drug Discovery CollaborationCocrystal Pharma, HitGen and InterX Enter into Drug Discovery Collaboration
finance.yahoo.com - September 5 at 6:59 PM
Cocrystal Announces Positive Data from the Successful Completion of Phase 1a/1b Trial of the Non-Nucleoside Polymerase Inhibitor CC-31244 for the Treatment of Chronic Hepatitis C InfectionCocrystal Announces Positive Data from the Successful Completion of Phase 1a/1b Trial of the Non-Nucleoside Polymerase Inhibitor CC-31244 for the Treatment of Chronic Hepatitis C Infection
finance.yahoo.com - August 15 at 6:07 PM
PolarityTE: Will This Biotech Be The Next Amazon Or Tesla?PolarityTE: Will This Biotech Be The Next Amazon Or Tesla?
www.forbes.com - August 8 at 5:07 PM
Cocrystal Pharma Announces Filing 2017 Second Quarter Financial Statements and Provides Company UpdateCocrystal Pharma Announces Filing 2017 Second Quarter Financial Statements and Provides Company Update
finance.yahoo.com - August 8 at 5:07 PM
MDCO Tastes Bitter, PRTO Awaits Phase 3 Data In Dec., Its Time To Cherish IONSMDCO Tastes Bitter, PRTO Awaits Phase 3 Data In Dec., It's Time To Cherish IONS
www.nasdaq.com - November 8 at 12:56 PM
COCRYSTAL PHARMA, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security HoldersCOCRYSTAL PHARMA, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
biz.yahoo.com - July 29 at 4:18 PM
COCRYSTAL PHARMA, INC. Files SEC form 10-K, Annual ReportCOCRYSTAL PHARMA, INC. Files SEC form 10-K, Annual Report
biz.yahoo.com - March 15 at 5:14 PM
COCRYSTAL PHARMA, INC. Files SEC form 8-K, Regulation FD DisclosureCOCRYSTAL PHARMA, INC. Files SEC form 8-K, Regulation FD Disclosure
biz.yahoo.com - February 12 at 5:11 PM
COCRYSTAL PHARMA, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and ExhibiCOCRYSTAL PHARMA, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibi
biz.yahoo.com - November 20 at 5:10 PM
COCRYSTAL PHARMA, INC. Files SEC form 10-Q, Quarterly ReportCOCRYSTAL PHARMA, INC. Files SEC form 10-Q, Quarterly Report
biz.yahoo.com - November 16 at 4:16 PM
COCRYSTAL PHARMA, INC. Files SEC form 8-K, Change in Directors or Principal OfficersCOCRYSTAL PHARMA, INC. Files SEC form 8-K, Change in Directors or Principal Officers
biz.yahoo.com - October 2 at 4:07 PM

SEC Filings

Cocrystal Pharma (OTCMKTS:COCP) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Financials are not available for this stock.

Chart

Cocrystal Pharma (OTCMKTS COCP) Stock Chart for Wednesday, January, 17, 2018

Loading chart…

This page was last updated on 1/17/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.